Glucose-responsive Insulinoma with Insulin Hypersecretion Suppressed by Metformin

Intern Med. 2019 Dec 15;58(24):3563-3568. doi: 10.2169/internalmedicine.3318-19. Epub 2019 Aug 28.

Abstract

In type 2 diabetes mellitus, metformin suppresses excessive insulin secretion in relation to the intake of glucose. We herein report the case of a 45-year-old man with glucose-responsive insulinoma whose responsive hypoglycemia was alleviated by metformin. The patient had a history of a postprandial loss of consciousness, resulting in hospital admission. He refused surgery and diazoxide administration. A 75-g oral glucose tolerance test after metformin administration revealed the suppression of glucose-responsive insulin hypersecretion and responsive hypoglycemia. Pancreatic head duodenectomy was performed, which alleviated the symptoms. Metformin administration in patients with glucose-responsive insulinoma may therefore be effective for preventing responsive hypoglycemia and hyperinsulinemia.

Keywords: case report; insulinoma; metformin; postprandial; responsive hypoglycemia.

Publication types

  • Case Reports

MeSH terms

  • Glucose Tolerance Test
  • Humans
  • Hypoglycemia / etiology
  • Hypoglycemia / prevention & control*
  • Hypoglycemic Agents / pharmacology
  • Hypoglycemic Agents / therapeutic use*
  • Insulin / metabolism*
  • Insulinoma / complications
  • Insulinoma / metabolism*
  • Insulinoma / pathology
  • Male
  • Metformin / pharmacology
  • Metformin / therapeutic use*
  • Middle Aged
  • Pancreatic Neoplasms / complications
  • Pancreatic Neoplasms / metabolism*
  • Pancreatic Neoplasms / pathology
  • Postprandial Period

Substances

  • Hypoglycemic Agents
  • Insulin
  • Metformin